[How expensive is treatment of reflux disease?].
In a prospective documented series of reflux patients, a retroelective analysis of medication cost and duration of conservative therapy as well as the costs for surgical therapy including preoperative diagnostic workup, cost during hospitalization, and costs for complications with necessary additional treatment and readmissions is assessed. Cost-relevant factors are in conservative treatment cost-relevant factors are those patients who need increasing dosages, while in surgical treatment the cost-relevant patients are those with complications who need additional treatment.
Fuchs
K H
KH
Chirurgische Universitätsklinik und Poliklinik, Würzburg.
Tigges
H
H
Heimbucher
J
J
Freys
S M
SM
Thiede
A
A
D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics*; D003362:Cost-Benefit Analysis; D018662:Fundoplication / Q000191:economics*; D005764:Gastroesophageal Reflux / Q000188:drug therapy / Q000191:economics* / Q000601:surgery; D005858:Germany; D006801:Humans; D010535:Laparoscopy / Q000191:economics; D007902:Length of Stay / Q000191:economics; D010359:Patient Readmission / Q000191:economics; D011183:Postoperative Complications / Q000188:drug therapy / Q000191:economics* / Q000601:surgery; D012086:Reoperation; D012189:Retrospective Studies
D000897:Anti-Ulcer Agents
Wie teur ist die Behandlung der Refluxkrankheit?